Cost-effectiveness of initial versus delayed lanreotide for treatment of metastatic enteropancreatic neuroendocrine tumors

James I. Barnes, John K. Lin, Divya Gupta, Douglas K. Owens, Jeremy D. Goldhaber-Fiebert, Pamela L. Kunz

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of initial versus delayed lanreotide for treatment of metastatic enteropancreatic neuroendocrine tumors'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science